Almirall LLC
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$10.3M
Doctors Paid
9,438
Transactions
45,341
2024 Total
$945,338
Payment Breakdown by Category
Research$5.6M (54.3%)
Consulting$1.9M (18.6%)
Food & Beverage$966,932 (9.4%)
Travel$239,983 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $5.6M | 581 | 54.3% |
| Consulting Fee | $1.9M | 753 | 18.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.4M | 677 | 14.0% |
| Food and Beverage | $966,932 | 42,581 | 9.4% |
| Travel and Lodging | $239,983 | 578 | 2.3% |
| Grant | $108,840 | 1 | 1.1% |
| Honoraria | $24,100 | 10 | 0.2% |
| Education | $1,883 | 160 | 0.0% |
Payments by Type
Research
$5.6M
581 transactions
General
$4.7M
44,760 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| M14867-32 | $1.3M | 2 | 201 |
| Patient-reported Outcomes for Sarecycline Effectiveness and Safety (PROSES) | $537,956 | 32 | 147 |
| KLISYRI-IIS US Biomarkers Seykora | $435,617 | 1 | 3 |
| H2200518 - SEYSARA-IIS Dr. Bunick MOA Study | $330,607 | 0 | 2 |
| THE USE OF Sarecycline IN THE TREATMENT OF ROSACEA | $322,373 | 0 | 2 |
| SEYSARA IN THE TREATMENT OF ROSACEA | $322,373 | 0 | 1 |
| Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis (PROAK) | $265,401 | 4 | 58 |
| Elucidating Novel Therapeutic Targets in Hidradenitis Suppurativa | $247,569 | 0 | 4 |
| Mode of action of sarecycline on the bacterial ribosome | $236,984 | 0 | 2 |
| PROAK | $223,535 | 1 | 33 |
| M-27134-01 | $209,035 | 0 | 89 |
| IIS Dr Kircik Patient preference comparing two CAL/BPD fixed dose combinations | $122,000 | 1 | 3 |
| Sarecycline Truncal Acne Safety and Efficacy Response (TASER) Study | $105,000 | 0 | 2 |
| A patient preference study comparing two CAL/BDP fixed dose combinations used for the topical treatment of plaque psoriasis, one formulated as a cream Wynzora and the other as a foam Enstila | $100,000 | 0 | 2 |
| H2200555 KLISYRI-IIS US Tirba SCCIS Lain | $56,058 | 0 | 1 |
| ACZONE GEL IN THE TREATMENT OF ACNE VULGARIS | $52,004 | 0 | 5 |
| PhIV-IIS - RWE Tirbanibulin NMSC | $50,000 | 0 | 2 |
| Klisyri - IIS Dr. Feldman - Investigator-initiated Study of Field of Cancerization Size | $50,000 | 0 | 2 |
| Klisyri - IIS Dr. Feldman - Investigator-initiated Study of Patient Refusal FU | $41,029 | 0 | 2 |
| ROLE OF ANTIBIOTICS IN THE TREATMENT OF ACNE VULGARIS | $40,000 | 0 | 2 |
| IIS Dr. Lain - Tirbanibulin for sBCC – US | $37,373 | 0 | 1 |
| An open-label study to investigate the efficacy and tolerability of Aczone gel, 7.5% in the treatment of acne vulgaris in men and women with Fitzpatrick skin types IV-VI | $35,478 | 0 | 1 |
| Systematic Review of safety, tolerability and patient-reported outcomes of topical treatments in actinic keratosis | $30,000 | 0 | 2 |
| Klisyri - IIS Dr. Feldman - Investigator-initiated Study of Call Backs | $30,000 | 0 | 1 |
| PhIV-IIS - RWE Tirbanibulin for Condyloma Angela Yen Moore | $28,500 | 0 | 2 |
| Research | $20,000 | 0 | 1 |
| A Single-Center Pilot Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis | $20,000 | 1 | 1 |
| Perioral Dermatitis IIS | $17,610 | 1 | 2 |
| AD Survey testing | $2,400 | 1 | 2 |
Payments by Medical Specialty
Top Paid Doctors — Page 5
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Tien Nguyen, Md, MD | Dermatology | Fountain Valley, CA | $8,695 | $0 |
| Luis Garza, Md-Phd, MD-PHD | Dermatology | Baltimore, MD | $8,523 | $0 |
| Annabelle Garcia, Md, MD | Student in an Organized Health Care Education/Training Program | San Antonio, TX | $8,499 | $0 |
| Kristi Hawley, D.o, D.O | Dermatology | Caledonia, MI | $8,457 | $0 |
| Dr. Diane Berson | Dermatology | New York, NY | $8,457 | $0 |
| Sharon Kelly, Md, MD | Dermatology | Bellevue, WA | $8,398 | $0 |
| Stephen Hess, Md, MD | Dermatology | Philadelphia, PA | $8,333 | $0 |
| Dr. Joshua Berlin, Md, MD | Dermatology | Boynton Beach, FL | $8,130 | $0 |
| Dr. Sarah Jackson, M.d, M.D | Dermatology | New Orleans, LA | $7,809 | $0 |
| Nathalie Zeitouni, Md, MD | Dermatology | Phoenix, AZ | $7,724 | $0 |
| Kavita Sarin, Md, MD | Dermatology | Stanford, CA | $7,700 | $0 |
| Dr. Donald Savitz, M.d, M.D | Specialist | Stamford, CT | $7,694 | $0 |
| Mrs. Miriam Bettencourt, Md, MD | Dermatology | Las Vegas, NV | $7,680 | $0 |
| Dr. Brett King, Md, MD | Dermatology | Fairfield, CT | $7,580 | $0 |
| Ms. Fran Cook-Bolden, Md, MD | Dermatology | New York, NY | $7,569 | $0 |
| Sewon Kang, Md, MD | Dermatology | Baltimore, MD | $7,490 | $0 |
| Lisa Miller, Aprn-Cnp, APRN-CNP | Nurse Practitioner | Columbus, OH | $7,450 | $0 |
| Peter Vitulli, Do, DO | Dermatology | Jupiter, FL | $7,449 | $0 |
| Daniel Kaplan | Dermatology | Pittsburgh, PA | $7,440 | $0 |
| Michael Rosenblum, Md, MD | Internal Medicine | Albany, NY | $7,040 | $0 |
| Rebecca Smith, Md, MD | Dermatology | Fort Mill, SC | $7,009 | $0 |
| Kimberly Grande, M.d, M.D | Specialist | Knoxville, TN | $6,909 | $0 |
| John Kasteler, M.d, M.D | Dermatology | Gilbert, AZ | $6,804 | $0 |
| Andrew Blauvelt, Md, MD | Dermatology | Portland, OR | $6,798 | $0 |
| Jason Smith, M D, M D | Procedural Dermatology | Rome, GA | $6,772 | $0 |
About Almirall LLC
Almirall LLC has made $10.3M in payments to 9,438 healthcare providers, recorded across 45,341 transactions in the CMS Open Payments database. In 2024, the company paid $945,338. The top product by payment volume is Klisyri ($2.1M).
Payments were distributed across 111 medical specialties. The top specialty by payment amount is Dermatology ($4.1M to 4,066 doctors).
Payment categories include: Food & Beverage ($966,932), Consulting ($1.9M), Research ($5.6M), Travel & Lodging ($239,983).
Almirall LLC is associated with 6 products in the CMS Open Payments database, including Klisyri, Seysara, and SEYSARA.